These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32582769)

  • 1. Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor.
    Nahmias A; Stahel P; Xiao C; Lewis GF
    Front Cardiovasc Med; 2020; 7():100. PubMed ID: 32582769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis.
    Cardona A; O'Brien A; Bernier MC; Somogyi A; Wysocki VH; Smart S; He X; Ambrosio G; Hsueh WA; Raman SV
    BMJ Open Diabetes Res Care; 2019; 7(1):e000718. PubMed ID: 31798892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
    Rosenblit PD
    Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-Ankle Vascular Index as a Surrogate Marker of Early Atherosclerotic Cardiovascular Disease in Koreans with Type 2 Diabetes Mellitus.
    Park SY; Chin SO; Rhee SY; Oh S; Woo JT; Kim SW; Chon S
    Diabetes Metab J; 2018 Aug; 42(4):285-295. PubMed ID: 30113145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.
    Ali MK; Bullard KM; Saydah S; Imperatore G; Gregg EW
    Lancet Diabetes Endocrinol; 2018 May; 6(5):392-403. PubMed ID: 29500121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year atherosclerotic cardiovascular disease risk prediction for postmenopausal women: Impacts of isolated postchallenge hyperglycemia.
    Wu TH; Lin YC; Hwu CM
    Medicine (Baltimore); 2022 Sep; 101(36):e30352. PubMed ID: 36086734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization Patterns of Lipid-lowering Therapies in Patients With Atherosclerotic Cardiovascular Disease or Diabetes: A Population-based Study in South Korea.
    Kim S; Kim H; Kim E; Han S; Rane PP; Fox KM; Zhao Z; Qian Y; Suh HS
    Clin Ther; 2018 Jun; 40(6):940-951.e7. PubMed ID: 29735297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis.
    Malik S; Zhao Y; Budoff M; Nasir K; Blumenthal RS; Bertoni AG; Wong ND
    JAMA Cardiol; 2017 Dec; 2(12):1332-1340. PubMed ID: 29117273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sweet spot: continued search for the glycemic threshold for macrovascular disease-a retrospective single center experience.
    Boguszewski A; Teklinski A; Rosman H; Desai D; Ali S; Szpunar S; Moore R; Maciejko J
    ISRN Cardiol; 2012; 2012():874706. PubMed ID: 23097721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of fasting glucose levels with incident atherosclerotic cardiovascular disease: An 8-year follow-up study in a Chinese population.
    Liu F; Yang X; Li J; Cao J; Chen J; Li Y; Liu X; Zhao L; Shen C; Yu L; Huang J; Gu D
    J Diabetes; 2017 Jan; 9(1):14-23. PubMed ID: 26840038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relations of Postload and Fasting Glucose With Incident Cardiovascular Disease and Mortality Late in Life: The Cardiovascular Health Study.
    Brutsaert EF; Shitole S; Biggs ML; Mukamal KJ; deBoer IH; Thacker EL; Barzilay JI; Djoussé L; Ix JH; Smith NL; Kaplan RC; Siscovick DS; Psaty BM; Kizer JR
    J Gerontol A Biol Sci Med Sci; 2016 Mar; 71(3):370-7. PubMed ID: 26314953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors and glucose tolerance in midlife and risk of cognitive disorders in old age up to a 49-year follow-up of the Helsinki businessmen study.
    Rantanen K; Strandberg AY; Salomaa V; Pitkälä K; Tilvis RS; Tienari P; Strandberg T
    Ann Med; 2017 Sep; 49(6):462-469. PubMed ID: 28151011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk.
    Orringer CE; Jacobson TA; Maki KC
    J Clin Lipidol; 2019; 13(6):860-872. PubMed ID: 31787586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
    Rana JS; Tabada GH; Solomon MD; Lo JC; Jaffe MG; Sung SH; Ballantyne CM; Go AS
    J Am Coll Cardiol; 2016 May; 67(18):2118-2130. PubMed ID: 27151343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare resource utilization and costs in working-age patients with high-risk atherosclerotic cardiovascular disease: findings from a multi-employer claims database.
    Zhao Z; Zhu Y; Fang Y; Ye W; McCollam P
    J Med Econ; 2015; 18(9):655-65. PubMed ID: 25891183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.